- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Rafael Holdings Inc Class B (RFL)
Rafael Holdings Inc Class B stock price live, this page displays NYSE RFL stock exchange data. View the RFL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Rafael Holdings Inc Class B real time stock price chart below.
What Is the Rafael Holdings Inc Class B Stock Price Today?
The Rafael Holdings Inc Class B stock price today is 1.740.
What Is the Stock Symbol for Rafael Holdings Inc Class B?
The stock symbol for Rafael Holdings Inc Class B is ""RFL.""
What Stock Exchange Does Rafael Holdings Inc Class B Trade On?
Rafael Holdings Inc Class B is listed and trades on the NYSE stock exchange.
Is Rafael Holdings Inc Class B a Good Stock to Buy?
Determining whether Rafael Holdings Inc Class B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RFL quote. (ISIN: US75062E1064)
What Is the Rafael Holdings Inc Class B Stock Price Today?
The Rafael Holdings Inc Class B stock price today is 1.740.
What Is the Stock Symbol for Rafael Holdings Inc Class B?
The stock symbol for Rafael Holdings Inc Class B is ""RFL.""
What Stock Exchange Does Rafael Holdings Inc Class B Trade On?
Rafael Holdings Inc Class B is listed and trades on the NYSE stock exchange.
Is Rafael Holdings Inc Class B a Good Stock to Buy?
Determining whether Rafael Holdings Inc Class B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RFL quote. (ISIN: US75062E1064)
NYSE
Currency in USD
1.740
-0.010(-0.57%)
Closed·
After Hours
1.740-0.010(-0.57%)
·
Fair Value
An estimate of a Rafael B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.730
1.780
52 wk Range
1.280
3.190
RFL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
RFL is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Rafael B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7301.780
52 wk Range
1.2803.190
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RFL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Rafael B's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Form 8K Rafael Holdings Inc Class B For: 18 July
- Investing.com
- Form 8K Rafael Holdings Inc Class B For: 4 June
- Investing.com
- Form 8K Rafael Holdings Inc Class B For: 18 June
- Investing.com
- Form 8K Rafael Holdings Inc Class B For: 18 July
- Investing.com
- Form 8K Rafael Holdings Inc Class B For: 18 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Rafael Holdings Inc Class B Company Profile
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), a stable analog of transient, acylated catalytic intermediates of lipoate currently under phase 2 open-label multi-cohort study evaluating CPI-613 in combination with hydroxychloroquine and 5-fluorouracil or gemcitabine in patients with advanced chemorefractory colorectal, pancreatic, or other solid cancers; and under phase 1 dose-escalation study of CPI-613 in combination with chemoradiation in patients with pancreatic adenocarcinoma. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1A and 1B clinical studies targeting patients with advanced cancers; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrument for Carpal Tunnel syndrome. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
Compare RFL to Peers and Sector
Metrics to compare | RFL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRFLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | 0.0x | −0.5x | |
PEG Ratio | −0.11 | 0.01 | 0.00 | |
Price/Book | 0.8x | 0.7x | 2.6x | |
Price / LTM Sales | 83.4x | 5.1x | 3.3x | |
Upside (Analyst Target) | - | 22.2% | 43.5% | |
Fair Value Upside | Unlock | 6.1% | 6.3% | Unlock |
Earnings
Latest Release
Jun 11, 2025
EPS / Forecast
-0.19 / --
Revenue / Forecast
362.00K / --
People Also Watch
FAQ
What Stock Exchange Does Rafael B Trade On?
Rafael B is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Rafael B?
The stock symbol for Rafael B is "RFL."
What Is the Rafael B Market Cap?
As of today, Rafael B market cap is 61.06M.
What Is Rafael B's Earnings Per Share (TTM)?
The Rafael B EPS (TTM) is -0.92.
From a Technical Analysis Perspective, Is RFL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Rafael B Stock Split?
Rafael B has split 0 times.
How Many Employees Does Rafael B Have?
Rafael B has 30 employees.
What is the current trading status of Rafael B (RFL)?
As of 05 Aug 2025, Rafael B (RFL) is trading at a price of 1.74, with a previous close of 1.74. The stock has fluctuated within a day range of 1.73 to 1.78, while its 52-week range spans from 1.28 to 3.19.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.